Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
Study NCT ID:
NCT00963105
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2009-08-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-20
First Submit QC Date:
None
Study First Post Date:
2009-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-31
Results First Submit QC Date:
None
Results First Post Date:
2018-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-02
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL